Skip to main content
. 2015 Jun 8;10(2):1054–1062. doi: 10.3892/ol.2015.3335

Table III.

Relationship between Shimada pathological status and stage according to INSS of the studied neuroblastoma cases. Valid cases, n=64 (48.5%).

INSS

Pathology (Shimada classification), n (%) IVS IIB III IV Total Statistica P-value
Favorable 0 (0.0) 4 (14.3) 8 (28.6) 16 (57.1) 28 (100) 0.369 0.535
Unfavorable 4 (11.1) 0 (0.0) 8 (22.2) 24 (66.7) 36 (100)
Total 4 (6.3) 4 (6.3) 16 (25.0) 40 (62.5) 64 (100)
a

Cramer's V test. INSS, International Neuroblastoma Staging System.

HHS Vulnerability Disclosure